Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 175 (TMEM175) is a lysosomal ion channel that has a pivotal role in maintaining lysosomal membrane potential and pH homeostasis. Unlike canonical potassium channels, TMEM175 is evolutionarily distinct and lacks the typical selectivity filter, instead forming a unique homodimeric/pseudo-tetrameric architecture to conduct ions across the lysosomal membrane. TMEM175 functions as both a potassium-selective and a proton-selective channel, with the balance between these conductances determined by the lysosomal pH; it serves as a major K⁺ channel under neutral conditions but preferentially conducts protons under acidic conditions such as those found in lysosomes. The channel is critical for termination of excessive acidification by mediating a pH-activated proton leak, ensuring optimal lysosomal acidification for degradative functions. TMEM175 genetic variants are strongly associated with Parkinson’s disease risk, and its dysfunction is linked to impaired lysosomal activity, aggregation of α-synuclein, and altered neurodegeneration susceptibility. Pharmacological inhibitors like 4-aminopyridine and potential endogenous or synthetic modulators are under investigation for their ability to modulate TMEM175 activity for therapeutic purposes.
4-Aminopyridine: small-molecule inhibition by binding near the center of the open-state channel, blocking K⁺/H⁺ conduction; Agonists: activation of proton conductance to facilitate lysosomal pH regulation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 175 (TMEM175).